Masthead (Adv. Therap. 3/2022).
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 3, p. 1, doi. 10.1002/adtp.202270006
- Publication type:
- Article
Works matching IS 23663987 AND DT 2022 AND VI 5 AND IP 3
Results: 6
1
2
Targeting Macrophages and Synoviocytes Intracellular Milieu to Augment Anti‐Inflammatory Drug Potency (Adv. Therap. 3/2022).
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 3, p. 1, doi. 10.1002/adtp.202100167
- By:
- Publication type:
- Article
3
Targeting Macrophages and Synoviocytes Intracellular Milieu to Augment Anti‐Inflammatory Drug Potency.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 3, p. 1, doi. 10.1002/adtp.202100167
- By:
- Publication type:
- Article
4
Controllable Nitric Oxide‐Delivering Platforms for Biomedical Applications.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 3, p. 1, doi. 10.1002/adtp.202100227
- By:
- Publication type:
- Article
5
Inhibition of Collagenase Q1 of Bacillus cereus as a Novel Antivirulence Strategy for the Treatment of Skin‐Wound Infections.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 3, p. 1, doi. 10.1002/adtp.202100222
- By:
- Publication type:
- Article
6
Differential Macrophage Responses to Gold Nanostars and Their Implication for Cancer Immunotherapy.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 3, p. 1, doi. 10.1002/adtp.202100198
- By:
- Publication type:
- Article